GEne therapy - HealthQuill

Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene therapies for two genetic disorders.

Novartis to pay $100m upfront to Voyager for gene therapies

HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene.

by HealthQuill
January 3, 2024
0 Comments

The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.

Drugs Health Medical

Opinion: Sickle Cell Disease and gene therapy

By K. Leelamoni December 19, 2023: Recent reports about the FDA’s approval of gene therapy to treat Sickle Cell Anemia mark a major.

by HealthQuill
December 19, 2023
2 Comments

Health Medical Pharma

Gene to treat chronic muscle disorders found

HQ team November 13, 2023: Researchers at the University of California, Irvine, have identified a gene that helps in muscle repair during regeneration..

by HealthQuill
November 13, 2023
0 Comments

Drugs Health Medical Pharma

Gene therapy cure for sickle cell awaits advisory approval

HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.

by HealthQuill
October 28, 2023
0 Comments

Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for gene therapy projects.

Drugs Health Pharma

Alexion, Pfizer sign $1 billion accord for genomic medicines

HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for.

by HealthQuill
July 29, 2023
0 Comments

Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way for a new generation of treatments to prevent disease degeneration.

Drugs Health Pharma

Gene variant discovery may trigger new treatments for multiple sclerosis

HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.

by HealthQuill
July 5, 2023
0 Comments

Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through gene therapy.

Drugs Medical Pharma

FDA, EMA accept Pfizer’s BLP application for hemophilia therapy

HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.

by HealthQuill
June 27, 2023
0 Comments

Drugs Medical

FDA approves gene therapy for treatment of high-risk bladder cancer

The FDA approved Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating adenoviral vector-based gene therapy for the treatment of high-risk bladder cancer.